- Home
- HXHX vs EVOK Comparison
HXHX vs EVOK Comparison
Compare HXHX & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HXHX | EVOK |
|---|---|---|
| Founded | 2003 | 2007 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.8M | 18.4M |
| IPO Year | 2025 | 2013 |
Fundamental Metrics
Financial Performance| Metric | HXHX | EVOK |
|---|---|---|
| Price | $0.53 | $10.91 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 375.5K | 243.2K |
| Earning Date | 04-30-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | ★ $25,571,810.00 | $14,424,652.00 |
| Revenue This Year | N/A | $57.38 |
| Revenue Next Year | N/A | $59.57 |
| P/E Ratio | $2.01 | ★ N/A |
| Revenue Growth | N/A | ★ 67.40 |
| 52 Week Low | $0.48 | $1.94 |
| 52 Week High | $6.29 | $10.92 |
Technical Indicators
Market Signals| Indicator | HXHX | EVOK |
|---|---|---|
| Relative Strength Index (RSI) | 36.39 | 84.87 |
| Support Level | $0.49 | $10.66 |
| Resistance Level | $0.64 | $10.75 |
| Average True Range (ATR) | 0.10 | 0.06 |
| MACD | 0.01 | -0.16 |
| Stochastic Oscillator | 10.67 | 96.74 |
Price Performance
Historical ComparisonAbout HXHX Haoxin Holdings Limited Class A Ordinary Shares
Haoxin Holdings Ltd is engaged in the logistics industry, including container provider of temperature-controlled truckload service and urban delivery services in China, freight forwarding, cold chain transportation and other businesses. The types of goods involved are all kinds of new energy materials that require low temperature, heat preservation, and constant temperature, electronic products, medicines, meat, fruits, vegetables and others.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.